Position in NEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$41,681,122
-$12,800,617 QoQ
Shares Held
5,617,402
+21.3% QoQ
Ownership
4.31%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BRAIDWELL LP holds $263,321,893 across 9 Diagnostics & Research names. NEO ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
499,712 | $46,158,397 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
92,915 | $45,670,509 | |
| 3 | NEO |
Neogenomics Inc
This page
|
5,617,402 | $41,681,122 | |
| 4 | CDNA |
CareDx, Inc.
|
2,173,146 | $37,725,814 | |
| 5 | ILMN |
Illumina, Inc.
|
229,215 | $28,253,040 | |
| 6 | DHR |
Danaher Corp /De/
|
139,327 | $26,416,399 | |
| 7 | NTRA |
Natera, Inc.
|
129,000 | $25,798,710 | |
| 8 | GRAL |
GRAIL, Inc.
|
142,755 | $7,377,578 |
All Filings in NEO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,681,122 | 5,617,402 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,481,739 | 4,632,801 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,673,247 | 1,771,146 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||